Dow Up0.51% Nasdaq Up0.24%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NMS
91.72 Up 1.98(2.21%) Nov 21, 4:00PM EST
|After Hours : 91.72 0.00 (0.00%) Nov 21, 5:00PM EST
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (89,225) (106,014) (57,649)
Operating Activities, Cash Flows Provided By or Used In
Depreciation10,229  9,035  5,125  
Adjustments To Net Income18,457  (9,665)21,384  
Changes In Accounts Receivables(4,144)1,364  1,982  
Changes In Liabilities(2,822)(13,889)(71,310)
Changes In Inventories -   -   -  
Changes In Other Operating Activities(1,152)3,560  13,400  
Total Cash Flow From Operating Activities (68,657) (115,609) (87,068)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(4,006)(8,348)(1,291)
Investments(126,499)11,884  83,250  
Other Cash flows from Investing Activities -  (162) -  
Total Cash Flows From Investing Activities (130,505) 3,374   81,959  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock202,315  93,771  738  
Net Borrowings -   -   -  
Other Cash Flows from Financing Activities(1,389)(359) -  
Total Cash Flows From Financing Activities 200,926   93,412   738  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents 1,764   (18,823) (4,371)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.